Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ISRCTN52550559) titled 'Expression of CUG2, ßIGH3 (TGFBI), and TGF-ß in bronchoscopic biopsy specimens of lung cancer patients' on June 11.
Study Type: Observational
Study Design:
Prospective observational diagnostic accuracy study
Primary Sponsor: Suleyman Demirel University
Condition:
Lung cancer
thoracic malignancy
lung neoplasms
bronchoscopic biopsy
metastasis
differential diagnosis
Cancer
Intervention:
This is a prospective observational diagnostic accuracy study. No intervention was administered to participants.
Index test: Quantitative real-time PCR (qPCR) measurement of CUG2, ßIGH3 (TGFBI), and TGF-ß g...